Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer

Anti-cancer Drugs
D Hochhauser

Abstract

Alterations in the expression of genes affecting cell cycle progression occur in all human cancers. These may occur either by overexpression of genes such as cyclin D1, mutation of regulatory genes such as p16, or abrogation of checkpoints following DNA damage as in the cases of mutation or deletion of the p53 gene. Perturbation of the normal functions of these genes has a profound effect on cellular proliferation, differentiation and apoptosis. There is increasing evidence that such alterations may modulate the cellular response to treatment with chemotherapeutic agents. In many cases genetic alterations may induce resistance to drug treatment as in the case of mutations of the p53 gene. However, the deregulated expression of cell cycle genes may also increase sensitivity to treatment by directly altering the expression of the target for chemotherapeutic drugs as in the case of deletion of the retinoblastoma gene. It is crucial to understand the interactions between drug mechanisms of action and the genetic alterations in cancer to exploit potential areas in which the alterations found in tumors may constitute potential vulnerability.

Citations

Jul 31, 1998·Hematology/oncology Clinics of North America·R M Zwacka, M G Dunlop
Jul 8, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y ShimadaM Imamura
Sep 16, 2008·Bioconjugate Chemistry·Thomas Tyrel GoodmanSuzie Hwang Pun
Oct 7, 2010·Nutrition and Cancer·Sanjeev BanerjeeRamzi M Mohammad
Feb 5, 2008·Pharmacogenomics·Marc Ansari, Maja Krajinovic
Jul 21, 2007·Cancer Treatment Reviews·George Pentheroudakis, Nicholas Pavlidis
Sep 18, 2008·International Journal of Cancer. Journal International Du Cancer·Haiming DingSteven M D'Ambrosio
Nov 30, 2005·The International Journal of Biochemistry & Cell Biology·Hala Gali-MuhtasibRegine Schneider-Stock
Jun 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew S Davids, Anthony Letai
Mar 18, 2008·Arquivos de neuro-psiquiatria·Mário Henrique Girão FariaSilvia Helena Barem Rabenhorst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis